Table 3: The pharmacokinetic profiles of the top-scoring compounds.
|
|
GI Absorption |
Pgp substrate |
CYP1A2 inhibitor |
CYP2C19 inhibitor |
CYP2C9 inhibitor |
CYP2D6 inhibitor |
CYP3A4 inhibitor |
|
C1 |
High |
No |
Yes |
No |
No |
No |
No |
|
C2 |
High |
No |
Yes |
No |
Yes |
No |
No |
|
C3 |
High |
No |
No |
No |
No |
No |
No |
|
C4 |
High |
No |
No |
No |
No |
No |
No |
|
C5 |
High |
No |
No |
No |
No |
No |
No |
|
C6 |
High |
No |
No |
No |
No |
No |
No |
|
C7 |
High |
No |
No |
No |
No |
No |
No |
|
C8 |
High |
No |
No |
Yes |
No |
No |
No |
|
C9 |
High |
No |
No |
Yes |
No |
No |
No |
|
C10 |
High |
No |
No |
No |
No |
No |
No |
|
C11 |
High |
No |
No |
No |
No |
No |
No |
C1 = Myristic Acid, C2 = Palmitic Acid, C3 = Xanthinin, C4 = 2,3-Dehydro-4-oxo-beta-ionol, C5 = Coniferyl alcohol, C6 = alpha-D-glucopyranoside, C7 = Ambrosiol, C8 = 2,3,5,5,8a-pentamethyl-6,7,8,8a-tetrahydro-5H-chromen-8-ol, C9 = (7E)-2,6,6-Trimethyl-3-methylene-7-(3-oxobutylidene) oxepanyl acetate, C10 = (8S,14)-cedran-diol, C11 = 3-oxo-10(14)-epoxyguai-11(13)-en-6,12-olide